Position in OCUL
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$164,239
+$150,493 QoQ
Shares Held
16,725
+21.7% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#181
of 257 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in OCUL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NewEdge Advisors, LLC holds $47,755,733 across 102 Biotechnology names. OCUL ranks #36 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
18,435 | $9,157,217 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
11,911 | $7,426,984 | |
| 3 | NUVB |
Nuvation Bio Inc.
|
1,231,733 | $6,996,243 | |
| 4 | INCY |
Incyte Corp
|
34,605 | $3,922,822 | |
| 5 | PHAT |
Phathom Pharmaceuticals, Inc.
|
203,962 | $2,212,987 | |
| 6 | EXEL |
Exelixis, Inc.
|
32,532 | $1,770,066 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
27,287 | $1,561,362 | |
| 8 | RPRX |
Royalty Pharma plc
|
21,597 | $1,210,943 |
All Filings in OCUL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $164,239 | 16,725 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $13,746 | 13,746 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $12,140 | 1,000 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $11,690 | 1,000 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $13,734 | 1,480 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $10,848 | 1,480 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $12,639 | 1,480 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $12,876 | 1,480 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $10,123 | 1,480 | Shares | Sole | 2024-08-16 | |
| 2024-03-31 | $13,468 | 1,480 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $6,600 | 1,480 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $4,647 | 1,480 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $64,396 | 12,480 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $7,799 | 1,480 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $29,448 | 10,480 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $43,492 | 10,480 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $46,149 | 11,480 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $56,826 | 11,480 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $93,955 | 13,480 | Shares | Sole | 2022-02-17 | |
| 2021-09-30 | $134,800 | 13,480 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $195,400 | 13,780 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $226,129 | 13,780 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $396,467 | 19,153 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $167,267 | 21,980 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $199,753 | 23,980 | Shares | Sole | 2020-07-29 | |
| 2020-03-31 | $121,176 | 24,480 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||